HEATHER LONARDO: Open Payments
NPI 1568210110 · PLAINFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 74 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $349 · 2025 $1,565
Food & beverage: $1,541Education: $24
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $246 |
| Novo Nordisk Inc | 8 | $242 |
| ABBVIE INC. | 17 | $212 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $132 |
| GlaxoSmithKline, LLC. | 5 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
Products named: FANAPT, Ozempic, Kerendia, VRAYLAR, QULIPTA, JARDIANCE, NUCALA, CAPLYTA.
Industry payments across CT — which companies pay providers there.
